Revelo acquired
The acquisition combined share consideration, cash and assumed liabilities. The acquired exploration assets were not a producing business.
Austral Gold returned to profit in FY2025, but the turnaround was broader than mine output alone. Higher realised prices, Casposo’s restart, investment gains and an impairment reversal all matter. The cash improvement is real in the annual record; the remaining current-liability deficit is equally important.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Up from US$36.790m.
Positive after the FY2024 cash outflow.
Includes investment and impairment effects.
Issuer measure at December 2025.
The portfolio moved through lower Guanaco/Amancaya output, asset sales and impairments before Casposo resumed commercial production in October 2025. Combined FY2025 output remained below FY2024 on the issuer-reported GEO series, despite the added Casposo contribution.
The issuer attributes the revenue recovery to Casposo and higher realised gold and silver prices. Separately, gains on securities and a Casposo impairment reversal lifted statutory earnings. They should not be folded into mining margins or portrayed as all-cash operating profit.
The acquisition combined share consideration, cash and assumed liabilities. The acquired exploration assets were not a producing business.
Heap-reprocessing construction began and the Pingüino sale was agreed. Sale completion and its first cash receipt occurred in March 2023.
The Pingüino disposal completed while closing cash remained low. The net cash figure includes the bank overdraft, unlike gross bank cash.
Amancaya mine and plant assets and several exploration properties were impaired. These charges reduced earnings and carrying amounts, not cash by the same amount.
Casposo began commercial production in October. A late-August workplace fatality led to a temporary Guanaco circuit suspension, affecting output and unit costs.
Gross profit strengthened with the price and operating mix change. The five-year revenue series should be read beside production and the earnings adjustments, rather than explained by tonnes or ounces alone.
US$ million
AI-generated presentation · values from The five-year revenue and earnings record; no missing values plotted as zero.
US$ million
AI-generated presentation · values from The five-year revenue and earnings record; no missing values plotted as zero.
US$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Sales revenue | 64.390 | 49.710 | 47.729 | 36.790 | 51.170 |
| Gross profit | 12.270 | 2.566 | 0.546 | 3.557 | 16.707 |
| Profit / (loss) attributable to owners | (7.324) | (8.257) | (7.229) | (27.068) | 14.726 |
Attributable earnings are used consistently; they are not comprehensive income or adjusted earnings.
The FY2025 result includes investment gains and an impairment reversal. It must not be interpreted as profit entirely from mining.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2025 operating inflow supported new plant spending, principally at Casposo. Disposal proceeds reduced the net investing outflow; they are not deducted from gross capex to suggest the plant cost less. Reclassified comparatives are used deliberately.
US$ million
AI-generated presentation · values from Cash flows and cash net of overdraft; no missing values plotted as zero.
US$ million
AI-generated presentation · values from Cash flows and cash net of overdraft; no missing values plotted as zero.
US$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 11.310 | 10.953 | 8.132 | (6.492) | 9.252 |
| Investing cash flow | (18.471) | (11.595) | (12.425) | 5.030 | (2.475) |
| Net financing cash flow | (2.894) | (0.778) | 4.406 | 3.814 | 0.363 |
| Closing cash - cash-flow basis, net of overdraft | 2.346 | 0.926 | 1.039 | 3.391 | 10.531 |
| PP&E cash payments | (6.897) | (6.434) | (11.283) | (0.434) | (7.904) |
| Exploration cash payments | (8.390) | (5.790) | (4.614) | (0.928) | (0.468) |
FY2022 uses the FY2023 restated cash-flow categories; FY2023 uses later reclassified comparatives. FY2025 also changed presentation to the direct method.
FY2023/FY2024 cash is net of US$0.222m/US$0.199m bank overdraft. Gross balance-sheet cash is not forced to match these figures.
Positive FY2024 investing cash includes asset disposals. It is not negative capex or recurring operating earnings.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Casposo contributed 4,283 GEOs after restart while Guanaco/Amancaya contributed 11,109 GEOs. Casposo’s stockpile-based costs are not a direct benchmark for Guanaco’s disrupted operations. C1 and AISC are issuer-defined measures, not IFRS cost-of-sales margins.
Issuer-reported gold-equivalent ounces
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Gold-equivalent production, reported operating portfolio | 31,142 | 27,686 | 24,879 | 15,573 | 15,392 |
FY2021-FY2024: Guanaco/Amancaya. FY2025: combined operations including Casposo after its October restart.
Issuer gold-equivalent conversion ratios vary across periods and sites; this is not a constant-price metal-equivalent series. FY2025 indicators exclude disclosed commissioning output.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
US$ per issuer-reported GEO
| Metric | Guanaco/Amancaya | Casposo | Combined |
|---|---|---|---|
| C1 cash cost | 2,602 | 1,387 | 2,264 |
| All-in sustaining cost | 2,834 | 1,638 | 2,501 |
C1 includes mine, plant, site G&A, smelting, refining and royalties, excluding corporate G&A. AISC adds sustaining capex, brownfield exploration and mine-closure amortisation.
Casposo costs reflect stockpile processing after restart; Guanaco was affected by a temporary circuit suspension. These are not identical operating conditions.
Guanaco and Casposo used different AuEq conversion ratios (84.6:1 and 72.1:1 silver:gold). Cost units follow the explicit issuer explanations rather than inconsistent KPI row labels.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
The latest result includes US$12.980m of gains on equity securities and a US$3.689m PP&E impairment reversal. Their effect must remain visible even though operating cash flow also improved. The reversal relates to Casposo; the major prior-year plant impairment related to Amancaya.
US$ million
AI-generated presentation · values from Equity through impairments and the earnings recovery; no missing values plotted as zero.
US$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Investment sale and fair-value gains | 1.724 | 12.980 |
| PP&E impairment reversal / (charge) | (16.705) | 3.689 |
Selected components only, not a complete earnings bridge.
The extraction gives two different FY2024 adjusted-earnings comparatives. No non-IFRS adjusted-earnings trend is published from that conflict.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
US$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total group equity | 57.098 | 48.815 | 41.573 | 14.365 | 29.696 |
The equity balance is not cash or a mineral-resource valuation. FY2024 was affected by substantial impairments.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Current liabilities still exceeded current assets at year-end. The major shareholder’s assurance on calling certain loans and the February 2026 placement informed the going-concern assessment. The placement is a subsequent event, not FY2025 cash.
Inventory described at fair value in the issuer’s liquidity discussion is not added to cash here. Debt reduction and a higher cash balance improve flexibility, but the large short-term debt portion remains relevant.
US$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Gross balance-sheet cash | 3.590 | 10.531 |
| Total financial debt | 26.595 | 26.571 |
| Issuer-reported net financial debt | 23.005 | 16.040 |
| Net current assets / (deficiency) | (5.823) | (6.371) |
FY2024 working-capital deficiency is calculated from US$20.177m current assets less US$26.000m current liabilities; both references are retained.
FY2025 short-term financial debt was US$20.060m. Support from the major shareholder and a subsequent capital raising formed part of the going-concern assessment; neither reclassifies all current debt as long-term.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.